Skip to content
Medical Health Aged Care

Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine

Medisca 3 mins read
PLATTSBURGH, N.Y.--BUSINESS WIRE--

Medisca, a global leader in personalized pharmaceutical solutions, held a grand opening event on June 20, 2024, for their new repackaging and distribution facility in Plattsburgh, New York. The event was celebrated in the company of Medisca’s valued Plattsburgh team, business partners, and state and federal officials, including Congresswoman Elise Stefanik, Senator Dan Stec, and Assemblyman Billy Jones.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240627482773/en/

Left to right: Mitchell Rubin, Medisca CFO | Assemblyman Billy Jones | Stephane Nizri, Medisca Head of Engineering | Sanjay Goorachurn, Medisca CEO | Antonio Dos Santos, Medisca Founder and Chairman | Maria Zaccardo, Medisca Co-Founder and Vice-Chair | Congresswoman Elise Stefanik | Panagiota Danopoulos, Medisca SVP Global Strategy and Innovation | Senator Dan Stec | Larry Harney, Medisca Operations Manager (Photo: Business Wire)

Left to right: Mitchell Rubin, Medisca CFO | Assemblyman Billy Jones | Stephane Nizri, Medisca Head of Engineering | Sanjay Goorachurn, Medisca CEO | Antonio Dos Santos, Medisca Founder and Chairman | Maria Zaccardo, Medisca Co-Founder and Vice-Chair | Congresswoman Elise Stefanik | Panagiota Danopoulos, Medisca SVP Global Strategy and Innovation | Senator Dan Stec | Larry Harney, Medisca Operations Manager (Photo: Business Wire)

"This event marks the completion of the largest project ever undertaken by Medisca in our 35-year history," said Antonio Dos Santos, Medisca Founder and Chairman. “This new facility showcases the diligent efforts and dedication of Medisca people and demonstrates our commitment to supporting the growing demands in personalized medicine."

Continued investment in the North Country

After 32 years of established standing and investment in the North Country, the opening of the new Medisca facility in Plattsburgh exemplifies the value of the workforce in this region.

"The new Medisca facility is a testament to our local workforce talent pool, already providing 65 good-paying local jobs with plans for further expansion," said Congresswoman Elise Stefanik. "This significant investment in Plattsburgh underscores the strength of our region. I am proud to support Medisca and the many industries investing in our community and driving economic prosperity for hardworking families in Upstate and the North Country."

Doubling capacity to serve the growing demands in personalized medicine

Consolidating existing operations into a single site equipped with innovative machinery and automated workflows, the new facility will significantly enhance the company’s capacity to support the diverse healthcare groups it serves.

“In particular, the new facility will allow Medisca to expand its capacity to provide quality products to pharmacists and healthcare professionals, so they can prepare personalized and essential medications for patients like you and me – not just here in the United States, but across the globe,” said Sanjay Goorachurn, Medisca CEO.

Leveraging scalable innovation, reinforcing established quality systems, and prioritizing the health, safety, and wellness of Medisca personnel were paramount in every decision made during the design and construction of the new facility. Key considerations included introducing custom-tailored ISO-rated production rooms and leveraging customized warehouse management systems for end-to-end traceability.

“Taken together, the new facility is a state-of-the-art example that leverages innovation and rigorous quality and safety measures to protect our product, personnel, and environment,” said Dos Santos.

The new Medisca Plattsburgh facility has undergone a successful New York State inspection and third-party documentation and systems audit, with additional licensures and agency inspections actively underway to serve the United States and Global markets. For a look at the new facility, click here.

About Medisca

Founded in 1989, Medisca is a global leader in personalized medicine and pharmaceutical supply chain solutions. Its vast portfolio of over 2,000 products is complemented by a library of 10,000+ proprietary and customized medication formulas, expertise, and services in pharmaceutical compounding, continuing healthcare education, analytical testing, and more. Providing finely-tuned solutions to diverse wellness sectors across the globe, Medisca is bridging the gaps in healthcare and empowering personalized wellness for all. For more information, visit www.medisca.com and follow us on LinkedIn, Facebook, and YouTube.


Contact details:

Medisca Communications
[email protected]
1-800-665-6334

Media

More from this category

  • Medical Health Aged Care
  • 29/04/2025
  • 00:10
Olon SpA

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech, the division dedicated to CDMO services for biologics. These appointments reinforce Olon's strategy to expand its capabilities in Antibody-Drug Conjugates (ADCs), Highly Potent Active Pharmaceutical Ingredients (HPAPIs), and microbial bioproduction.An Integrated Vision for ADCs, HPAPIs, and Microbial BioproductionWith this new leadership structure, Olon Group is accelerating the development of its fully integrated ADC offering, covering the entire value chain from Cell Line Development (CLD) to…

  • Medical Health Aged Care
  • 28/04/2025
  • 22:41
Mainstay Medical Holdings plc

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

DUBLIN--BUSINESS WIRE-- Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s policyholders. “We have been on a 17-year mission to prove the value of ReActiv8 through careful and thorough research,”said Jason Hannon, CEO of Mainstay Medical.“We have…

  • Medical Health Aged Care
  • 28/04/2025
  • 21:26
Eurosets

Life-saving Technologies at EuroELSO 2025: Eurosets Presents Landing Breathe and Xtreme Rescue

MILAN–BUSINESS WIRE– Eurosets, a cutting-edge Italian company specializing in the design of life-saving medical devices, unveils two crucial innovations at the EuroELSO 2025 congress:…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.